Back to search

Article

Bioinformatic determination of the expression and clinical value of the histone lysine demethylase family in prostate cancer

2022-03-29

Abstract excerpt

<h4>Background: </h4> As one of the most malignant tumors, prostate cancer (PCa) is a serious threat to the health of elderly men. The histone lysine demethylase (KDM) family regulates histone methylation and affects gene transcription during malignant transformation, which can lead to the occurrence of PCa. <h4>Methods: </h4>: We used bioinformatic methods to explore the expression and function of KDMs in PCa and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
40ada23a-8dd2-542f-81f3-04da06657055
DOI
10.21203/rs.3.rs-1486046/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Bioinformatic determination of the expression and clinical value of the histone lysine demethylase family in prostate cancerDOI 10.21203/rs.3.rs-1486046/v1
The emerging role of histone lysine demethylases in prostate cancerSemantic proximity
Integrative analyses of DNA methylase expression and related immune landscape in Prostate CancerSemantic proximity
A gene feature based on histone modifications can predict the prognosis of prostate cancerSemantic proximity
Subtypes of m6A RNA Modification Defines Tumor Microenvironment, Immunotherapy and Pharmacogenomic Landscape in Prostate CancerSemantic proximity
Prediction of Prognosis in Patients with Prostate Cancer by DNA Methylation ClassificationSemantic proximity
Deregulated expression of selected histone methylases and demethylases in prostate carcinomaSemantic proximity
Construction of risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validationSemantic proximity
m6A Methylation Regulators Are Predictive Biomarkers for Tumour Metastasis in Prostate CancerSemantic proximity
The Prognosis-Predictive and Immunoregulatory Role of SUMOylation Related Genes: Potential Novel Targets in Prostate Cancer TreatmentSemantic proximity
Integrated Multi-Omics Data Reveals the Molecular Subtypes of Prostate CancerSemantic proximity
Epigenetic-dysregulated lncRNAs in Prostate Cancer Based on Multi-omics AnalysisSemantic proximity
EZH2 as a Prognostic Factor and Its Immune Implication with Molecular Characterization in Prostate Cancer: An Integrated Multi-Omics in Silico AnalysisSemantic proximity
Select a neighboring publication to make it the new centre.